These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3292546)

  • 1. Major O-glycosylated sialoglycoproteins of human hematopoietic cells: differentiation antigens with poorly understood functions.
    Gahmberg CG; Autero M; Hermonen J
    J Cell Biochem; 1988 May; 37(1):91-105. PubMed ID: 3292546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early expression of glycophorin C during normal and leukemic human erythroid differentiation.
    Villeval JL; Le Van Kim C; Bettaieb A; Debili N; Colin Y; el Maliki B; Blanchard D; Vainchenker W; Cartron JP
    Cancer Res; 1989 May; 49(10):2626-32. PubMed ID: 2469535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens.
    Fukuda M; Carlsson SR
    Med Biol; 1986; 64(6):335-43. PubMed ID: 2950285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human red cell sialoglycoprotein, glycophorin A: biosynthesis, glycosylation and interaction with external ligands.
    Gahmberg CG; Hermonen J
    Indian J Biochem Biophys; 1988; 25(1-2):133-6. PubMed ID: 3053409
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of the major sialoglycoprotein (glycophorin) on erythroid cells in human bone marrow.
    Gahmberg CG; Jokinen M; Andersson LC
    Blood; 1978 Aug; 52(2):379-87. PubMed ID: 667363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a monoclonal antibody (GA3) to demonstrate lineage restricted O-glycosylation on leukosialin during terminal erythroid differentiation.
    Bettaieb A; Farace F; Mitjavila MT; Mishal Z; Dokhelar MC; Tursz T; Breton-Gorius J; Vainchenker W; Kieffer N
    Blood; 1988 May; 71(5):1226-33. PubMed ID: 2451948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes.
    Carlsson SR; Fukuda M
    J Biol Chem; 1986 Sep; 261(27):12779-86. PubMed ID: 2943740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of red cell membrane proteins in erythroid precursor cells.
    Yurchenco PD; Furthmayr H
    J Supramol Struct; 1980; 13(2):255-69. PubMed ID: 6941050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy.
    Fukuda M
    Glycobiology; 1991 Sep; 1(4):347-56. PubMed ID: 1840294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
    Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
    Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.
    Shelley CS; Remold-O'Donnell E; Davis AE; Bruns GA; Rosen FS; Carroll MC; Whitehead AS
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2819-23. PubMed ID: 2784859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.
    Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M
    J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA.
    Pallant A; Fukuda M; Frelinger JG
    Eur J Immunol; 1990 Jul; 20(7):1423-8. PubMed ID: 2143724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human erythroid cells is associated with increased O-glycosylation of the major sialoglycoprotein, glycophorin A.
    Gahmberg CG; Ekblom M; Andersson LC
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6752-6. PubMed ID: 6387712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica.
    Sutherland DR; Abdullah KM; Cyopick P; Mellors A
    J Immunol; 1992 Mar; 148(5):1458-64. PubMed ID: 1371528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
    Schopperle WM; DeWolf WC
    Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.